7-beta-Hydroxyepiandrosterone

DB06622InvestigationalSmall molecule

Investigated for use/treatment in alzheimer's disease.

Chemical structure of 7-beta-Hydroxyepiandrosterone
Primary indication
Investigated for use/treatment in alzheimer's disease.Curator reviewed
Formula / weight
C19H30O3 · 306.446 g/mol (avg)
Also known as
7beta-OH-Epia
Code names
HF-0220

Resolves to

Compound
UNIIOCP3E5KD08CAS25848-69-5
Structure
InChIKeyVFPMCLQMAUVEHD-UCPSWNCLSA-NSMILES[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@H](O)C[C@@]2([H])C[C@@H](O)CC[C@]12C
Targets
O60760HPGDS

What you can answer from here — as of January 29, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with 7-beta-Hydroxyepiandrosterone, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In